Clinical Trials · NCT02113332
Addition of Liraglutide to Patients With Type 2 Diabetes Treated With Multiple Daily Insulin Injections
- Phase
- Phase 2
- Recruitment status
- Completed
- Sponsor
- Vastra Gotaland Region
- Enrollment
- 124
- Start date
- Jan 2013
- Locations
- 14 sites, Sweden
- Primary endpoint
- Change in HbA1c from baseline to week 24.